drugset / Trial / NCT01311167
Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone
Phase 3
Terminated
2 enrolled
Insel Gruppe AG, University Hospital Bern
University Hospital, Geneva · collabUniversity of Lausanne Hospitals · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Accumulation of salt and water in patients with liver disease (so called liver cirrhosis) is possibly related to the increased effect of steroid hormones on salt reabsorption in the kidney. By reducing overall steroid production with the dexamethasone the accumulation of salt and water could be prevented.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-11
- Completion
- 2011-11
Outcome
Outcome not reported
Stopped (Enrollment): “Recruitment problems (not enough patients were found who met eligibility criteria)”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 2 mg | — |